financetom
Business
financetom
/
Business
/
--Artesian Resources Raises Quarterly Dividend by $0.0062 to $0.3136 a Share, Payable Nov. 24 to Holders of Record Nov. 14
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Artesian Resources Raises Quarterly Dividend by $0.0062 to $0.3136 a Share, Payable Nov. 24 to Holders of Record Nov. 14
Oct 30, 2025 12:49 PM

03:22 PM EDT, 10/30/2025 (MT Newswires) --

Price: 31.99, Change: -0.48, Percent Change: -1.48

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
West Red Lake Gold Reports Intersections at South Austin Zone of Madsen Mine
West Red Lake Gold Reports Intersections at South Austin Zone of Madsen Mine
Sep 24, 2024
06:26 AM EDT, 09/24/2024 (MT Newswires) -- West Red Lake Gold Mines ( WRLGF ) late on Monday reported new intersections at the high-grade South Austin Zone in the Madsen mine in Ontario. Highlights of the results include 49.4 grams per tonne (g/t) gold over 4.5 meters and 18.5 g/t gold over 11.2 meters. The South Austin Zone contains an...
BRIEF-Frontview REIT Expects IPO Price Of Common Stock To Be Between $17.00 And $21.00 Per Share - SEC Filing
BRIEF-Frontview REIT Expects IPO Price Of Common Stock To Be Between $17.00 And $21.00 Per Share - SEC Filing
Sep 24, 2024
Sept 24 (Reuters) - * FRONTVIEW REIT INC SAYS EXPECTS IPO PRICE OF COMMON STOCK TO BE BETWEEN $17.00 AND $21.00 PER SHARE - SEC FILING * FRONTVIEW REIT INC SEES IPO OF UP TO 13.2 MILLION SHARES OF COMMON STOCK * FRONTVIEW REIT INC SAYS INTENDS TO USE ABOUT $159.9 MILLION OF IPO NET PROCEEDS TO REPAY BORROWINGS UNDER...
Novo Nordisk CEO faces US Congress scrutiny over weight-loss drug pricing
Novo Nordisk CEO faces US Congress scrutiny over weight-loss drug pricing
Sep 24, 2024
Sept 24 (Reuters) - U.S. Senator Bernie Sanders is set to question Novo Nordisk CEO Lars Jorgensen on Tuesday over the drugmaker's prices for its popular weight-loss and diabetes medicines that can cost Americans more than $1,000 a month. Sanders is expected to challenge the CEO during a hearing of the Senate Committee on Health, Education, Labor and Pensions (HELP),...
Eli Lilly's Kisunla Gets Approval for Early Alzheimer's in Japan
Eli Lilly's Kisunla Gets Approval for Early Alzheimer's in Japan
Sep 24, 2024
06:48 AM EDT, 09/24/2024 (MT Newswires) -- Eli Lilly ( LLY ) said Tuesday that its Alzheimer's therapy Kisunla has received approval from Japan's Ministry of Health, Labour and Welfare for treatment of adults with early symptomatic Alzheimer's disease. Japan is Kisunla's second major market following US approval in July this year. Price: 919.20, Change: +0.68, Percent Change: +0.07 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved